• Zum Hauptinhalt springen
  • Zum Footer springen

PSY-PGx

  • About
    • Mission
    • Management & Structure
  • Consortium
  • Research
    • Work Packages
    • Careers
    • Publications
    • Clinical Study
  • Patients
    • Local Websites
    • Clinical Study
  • Media
    • Patient Experiences with Pharmacogenetics
    • Press Releases
    • Patient Inclusion
    • X (formerly Twitter)
  • Internal
  • Events
  • Meet the Team
  • News
  1. PSY-PGx
  2. News
  3. First Patient to Complete the Longitudinal PSY-PGx Clinical Study!
News | 24/08/2023
MILE STONE ACHIEVED IN CLINICAL STUDY

First Patient to Complete the Longitudinal PSY-PGx Clinical Study!

Congratulations to the PSY-PGx team at Study Center Amsterdam
This week Tuesday, the first patient reached the end of the PSY-PGx Clinical Study. We are looking forward for many more to follow suit!
Roos van Westrhenen

PSY-PGx

A New Intervention for Implementation of Pharmacogenetics in Psychiatry
PSY-PGx Coordinator

Roos van Westrhenen

Psychiatrist & Clinical Pharmacologist (MD, PhD) Parnassia Psychiatric Institute/St. John’s National Academy of Health Sciences, Bangalore, India/King’s College London

Overschiestraat 57
1062 HN Amsterdam, The Netherlands
pDsqguéicbpziudiuöcјæsuä

Sitemap

About
Consortium Members
Research
Patients
News
Internal


Funding

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 945151.

Twitter
Editor login
Imprint | Data-Safety